Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 August 2020 | Story Andre Damons
Follow these three easy steps to enter the Three-Minute Thesis Competition. Will you be this year’s winner?

 

The Three-Minute Thesis Competition, also known as the ‘3MT’, is an annual competition held at 200 universities around the world. It is open to PhD and master’s students, and challenges participants to present their research in just 180 seconds – in a way that is understood by an audience with no background in the research area. 


The UFS Postgraduate School was the first to bring the ‘Three-Minute Thesis’ (3MT) competition to Africa. The Three-Minute Thesis competition originates from the University of Queensland, Australia, and has now become an annual event at the UFS.

The competition aims to help participants develop presentation, research, and academic communication skills, as well as to support the development of research students’ ability to effectively explain their work. 
Although our country is in the midst of a pandemic, the annual competition continues. This year’s Three-Minute Thesis competition will be hosted online at
- The competition will first be hosted at the faculty level; faculty entries close at 14 August 2020

- Winners at faculty level will compete against each other at the Institutional level on 9 October 2020 and will stand a chance at winning these awesome cash prizes

UFS INSTITUTIONAL PRIZES FOR 2020 ARE:

Position Prizes 2020
Master’s winner R6 000
Master’s 1st runner-up R4 000
Master’s 2nd runner-up R2 000
PhD winner  R8 000
PhD 1st runner-up R6 000
PhD 2nd runner-up R4 000

 

Institutional winners will compete against other universities at the national level on 6 November 2020.


News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept